Rhinocare Korea has announced a Singapore-based joint venture to serve as its regional headquarters for drug-free respiratory therapy devices.

• Technology: The company’s “JetStream” device uses controlled warm steam therapy to address symptoms of rhinitis and sinusitis without medication.
• Regional Hub: The Singapore entity will oversee Asia-Pacific distribution, regulatory strategy, and future research and development.

This summary is based on a press release issued by Rhinocare Korea.